These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin. Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764 [TBL] [Abstract][Full Text] [Related]
3. Metal Ions Effectively Ablate the Action of Botulinum Neurotoxin A. Bremer PT; Pellett S; Carolan JP; Tepp WH; Eubanks LM; Allen KN; Johnson EA; Janda KD J Am Chem Soc; 2017 May; 139(21):7264-7272. PubMed ID: 28475321 [TBL] [Abstract][Full Text] [Related]
4. Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors. Li B; Cardinale SC; Butler MM; Pai R; Nuss JE; Peet NP; Bavari S; Bowlin TL Bioorg Med Chem; 2011 Dec; 19(24):7338-48. PubMed ID: 22082667 [TBL] [Abstract][Full Text] [Related]
5. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography. Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in botulinum neurotoxin inhibitor development. Kiris E; Burnett JC; Kane CD; Bavari S Curr Top Med Chem; 2014; 14(18):2044-61. PubMed ID: 25335887 [TBL] [Abstract][Full Text] [Related]
8. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A. Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358 [TBL] [Abstract][Full Text] [Related]
9. Structural insight into exosite binding and discovery of novel exosite inhibitors of botulinum neurotoxin serotype A through in silico screening. Hu X; Legler PM; Southall N; Maloney DJ; Simeonov A; Jadhav A J Comput Aided Mol Des; 2014 Jul; 28(7):765-78. PubMed ID: 24958623 [TBL] [Abstract][Full Text] [Related]
10. An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Eubanks LM; Hixon MS; Jin W; Hong S; Clancy CM; Tepp WH; Baldwin MR; Malizio CJ; Goodnough MC; Barbieri JT; Johnson EA; Boger DL; Dickerson TJ; Janda KD Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2602-7. PubMed ID: 17293454 [TBL] [Abstract][Full Text] [Related]
11. 8-Hydroxyquinoline and hydroxamic acid inhibitors of botulinum neurotoxin BoNT/A. Dickerson TJ; Smith GR; Pelletier JC; Reitz AB Curr Top Med Chem; 2014; 14(18):2094-102. PubMed ID: 25335884 [TBL] [Abstract][Full Text] [Related]
12. COVALENT INHIBITION OF BOTULINUM NEUROTOXIN A - EXPLORATION OF WARHEAD REACTIVITY AND FUNCTION USING A BIFUNCTIONAL APPROACH. Turner LD; Nielsen AL; Lin L; Pellett S; Sugane T; Olson ME; Janda KD Toxicon; 2021 Jan; 190(Suupl 1):S72-S73. PubMed ID: 34103769 [TBL] [Abstract][Full Text] [Related]
14. Post-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors. Ruthel G; Burnett JC; Nuss JE; Wanner LM; Tressler LE; Torres-Melendez E; Sandwick SJ; Retterer CJ; Bavari S Toxins (Basel); 2011 Mar; 3(3):207-17. PubMed ID: 22069707 [TBL] [Abstract][Full Text] [Related]
15. Benzoquinones as inhibitors of botulinum neurotoxin serotype A. Bremer PT; Hixon MS; Janda KD Bioorg Med Chem; 2014 Aug; 22(15):3971-81. PubMed ID: 24984937 [TBL] [Abstract][Full Text] [Related]
16. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme. Ambrin G; Kumar R; Singh BR Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744 [TBL] [Abstract][Full Text] [Related]
17. Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A. Jacobson AR; Adler M; Silvaggi NR; Allen KN; Smith GM; Fredenburg RA; Stein RL; Park JB; Feng X; Shoemaker CB; Deshpande SS; Goodnough MC; Malizio CJ; Johnson EA; Pellett S; Tepp WH; Tzipori S Toxicon; 2017 Oct; 137():36-47. PubMed ID: 28698055 [TBL] [Abstract][Full Text] [Related]
18. A high content imaging assay for identification of Botulinum neurotoxin inhibitors. Kota KP; Soloveva V; Wanner LM; Gomba G; Kiris E; Panchal RG; Kane CD; Bavari S J Vis Exp; 2014 Nov; (93):e51915. PubMed ID: 25489815 [TBL] [Abstract][Full Text] [Related]
19. Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E. Ben David A; Barnea A; Diamant E; Dor E; Schwartz A; Torgeman A; Zichel R Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445283 [TBL] [Abstract][Full Text] [Related]
20. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics. Behrensdorf-Nicol HA; Wild E; Bonifas U; Klimek J; Hanschmann KM; Krämer B; Kegel B Toxicol In Vitro; 2018 Dec; 53():80-88. PubMed ID: 30016653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]